- Currently, neurodegenerative conditions, Such as Parkinson’s and Alzheimer’s Diseases, Are Challenging to Prempt.
- A Large-Scale, Innovative New Study Research How Hormonal, Dietary, Metabolic, and Digestive Issues May Help Predict these conditions years Before They Begin.
- The Study Identificies Several Conditions that are associated with an increased Risk of Alzheimer’s and Parkinson’s.
- IMPORTENTLY, The Findings Also Hint at Ways to Help Reduce The Risk of Developing these disorders.
A New Study, Published in Science Advances, Research Links Between 155 Health Conditions and The Future Risk of Developing Alzheimer’s and Parkinson’s.
The scientists identified severe relativley easy-to-treat conditions that are Linked to the late revealopment of neurodegenerative condition, Years Before Symptoms Begin.
Additionionally, The Study Identify that the Timing of Each Condition Affects The Size of the Risk increased.
The Long Tail of Neurodegenerative Conditions
There are many verse of neurodegenerative desire – Marked by the Degradation of the Brain – Butinson’s and Alzheimer’s Are the Most Common.
EVENT DECADES OF FOCUS AND MILLIONS OF DOLLARS Worth of Research, They Remain Steadfastly Difficult to Predict and Treat.
Eleven these conditions begin, submit drarugs can Slow progress for submates; However, There is no cure, and no Surefire way to know who Will Develop Them.
Medical News Today Spoke with Lucy McCann, MBCHB, MSC, Anut, Medical Doctor and Registered Nutritonist, about the importance of this study.
“Alzheimer’s and Parkinson’s Disease Are Among the Most Common Neurodegenerative Disorders in The World. With an AGing Population, Preventing and Managing TheSe Conditions is Becoming A Public Health Priority,” McCann, Who Was Not Involved in the Research, Explained.
Research Has Also Shown That the Process Involved in The Diseases Begin Decades Before Symptoms Appear. Because of this, scientists are focusing on identifying any clues from myddle age that could provides Opportunities to Stop Disease Progression in Its Tracks.
Gut-Babain Axis: A Likely Suspect in Parkinson’s, Alzheimer’s Risk
In Recent Years, Scientists have focused on the potential role of the so-ranches Gut-Brain axis in neurodegenerative desire. In Short, The Gut-Brain Axis is Tway Communication Between The Gut and the Brain.
The Communication Has Many Modalities, Including:
- Hormonal, For Example Through Guth Peptides
- Nervous, eg the vagus nerve
- Immune, EG Cytokines.
These messaging pathways and more, as the authors of the new study explan, facilitate “Constant Interactions Between The Brain, Digestive, Endocrine, Metabolic Systems and Nutritional Status.”
The Nervous System of the Gut, Known as The Enterric Nervous System, Is The Second Largest Collection of Neurons Outsis of the Brain.
AT First Glance, It is difficult to understand why the brain and gut are so intimately linked. However, when we remumber that food is essential for our survival, and that we cannot find it without Our Brain, The Connections Begin to Make Sense.
When the Gut-Boin Axis is disruption, it can cause all Manner of Issues, Including Gut Pain, Mood disturbances, and irritable Bowel Syndrome (IBS).
IMPORTANTLY FOR THIS STUDY, THESE DISPRUPTIONS MAY ALSO INFFECTIVE AN INDIVIDUAL’S RISK OF DEVELOPING ALZHEIMER’S DIEW
How hormones and metabolism may contribute to risk
ALONGSIDE CONDIONES INVOLURE THE GUTI-BRAIN AXIS, SCIENTISTS HAVE ALSO IDENTIFIED LINKS BETWEEN Hormonal and METABOLIC CONDIONS AND AN INDIVIDUAL’S RISK OF DEVELOPING A NEURODEGENErative Condition.
For Instance, The Authors of the Recent Study Explain That More Severe Cases of Diabetes and Imbalances in Thyroid Hormones- Both Hypo- and Hyperthyroidism- Are Associated With Parkinson’s Disease. Similarly, Type 2 diabetes is a Well-Known Risk Factor for Alzheimer’s Disease.
Because of these links, Research Research Antidiabetic Drugs As a Potential Treatment forry of these neurodegenerative conditions.
At The Same Time, Soming Nutrient Deficiencies to Play a Part, Including
While these Findings Offer Sub Insight, Many Questions Remain. The Latest Study Sets Out To Bring Sub More Clarity to these varied and overlapping Associations.
Links with neurodegeneration: on the hunt for clarity
In The Latest Study, The Scientists Investigated Association Between Parkinson’s, Alzheimer’s, and 155 Disorders Associated With:
- The Endocrine System
- Nutritional Factors
- The Metabolic System
- The Digestive System.
Interestingly, The Scientists Designed Their Analysis to Examine How The Timing of these Conditions Influenced Future Risk by Stratifying The Data Into:
- 1–5 Years
- 5–10 Years
- and 10–15 Years Before An Alzheimer’s Or Parkinson’s Diagnosis.
Higher Alzheimer’s Risk Linked To 14 Chronic Conditions
The Researchers Found That 14 Diagnoses were Associated with an Increased Risk of Alzheimer’s Disease, Including:
- Amyloidosis – Conditions Characterized by A Buildup of Abnormal Proteins
- Disorders of Lipoprotein Metabolism and Other Lipidemias – Marked by Abnormal Levels of Fats, Such As High Triglycerides, In The Blood
- gastritis and duodenitis – inflammation of the stomach or the first section of the intestines
- Diabetes, Both Type 1 and Type 2
- Esophagitis – inflammation of the esophagus
- Intestinal Bacterial Infections
- Disorders of Fluid, Electrolyte, and Acid-Base Balance-The Include Hyponatremia (Low Sodium), Hypokalemia (Low Potassium), Hyperkalemia (High potassium), and acidosis or alkalosis (ABNORMAL BLOOD PH)
- Intestinal Intestinal Disorders – You
- Noninfective gastroenteritis and colitis – inflammation of the stomach and small intestine or colon that is not caused by bacteria or other pathogens
- Vitamin D Deficienty.
Conditions signantly Associated With A Later Diagnosis of Parkinson’s Disease Included:
- Dyspepsia – Chronic Indigestion
- Diabetes, Both Type 1 and Type 2
- other disorders of pancreatic internal secretion – incese disorders include diabetes, but also hypoglycemia (Low Blood Sugar) and Increased Glucagon Secret
- Intestinal Disorders
- deficiency of B vitamins.
MNT Spoke to David Perlmutter, MD, A Board-Certified Neurologist and Fellow of the American College of Nutrition, About the Study Findings.
“The Most Stiking Aspect is How Clearly The Study Links Systemic Disorders, particularly Thue Tied To The Gut-Branin Axis, With Neurodegeneration Risk Years Before Diagnosis,” Said Perlmutter, Who Was Not Involved in This Study.
“This Reinforces The View That Alzheimer’s and Parkinson’s Are Not Isolated Brain Desessuses But the End Stage of A Decades-Long, Body-Wide Process,” I have suggested.
Timing Matters
The Study Authors Investigated How the Timing of these conditions influenced future risk of developing to neurodegenerative condition.
For Instance, The Link Between Type 2 Diabetes and Alzheimer’s Was Strongest When Diagnosed 10–15 Years Earlier Compared With Later Diagnosis. This, The Refectchers Suggest, May Be Due to “Cumulative Metabolic Effects.”
By contrarasy, A Type 1 Diabetes Diagnosis Increase The Risk of Alzheimer’s To A Similar Extent Across All Three Time Windows.
For Parkinson’s, Type 1 Diabetes Was Most Strongly Associated When DiagnosD 5 to 10 Years Before the onsest of Parkinson’s, WHHEREAS TYPE 2 Diabetes Had A Similar Risk Across All Three Time Windows.
In general, when looking at all conditions together, the links with neurodegenerative conditions were Strongest When Diagnosed 10–15 Years Earlier.
The Authors Wrote That “(T) HESE Findings Underscore The Importance of Diagnosis Timing in Neurodegenerative Risk Modeling and Suggest That Bath Both Early-Life Exposures and Recent Comorbidities Contribute to Disease Vulnerability.”
Pay attention to potential signs of height had Alzheimer’s, Parkinson’s Risk
This Study Confirms Associations Between Health Conditions and the Risk of Developing Alzheimer’s And Parkinson’s. It also adds extra depth to Our Understanding.
The Authors Hope That By Drilling Down IndoSe Links, May Bends Being To Focus On Treatments and Potentially Reduces Even Prevent the onsest of these Challenging-To-Manage Neurodegenerative Conditions.
We Asked Perlmutter How the Results Might Help Reshape Prevention Strategies. I have explained that it will put a “Much Greater Emphasis on Maininting Metabolic, Endocrine, and Guth Health as a Means of Protecting the Brain.”
He Also Told Us That:
“Rather Than Waiting for Symptoms to emerge, Clinicicians and Individuals Could Use Systemic Health Markers, Such As Thyroid Status, Blood Sugar Control, Vitamin Levels, and Digestive Health, As Early Warning Signs of Elevated Risk.”
“What’s Clear from Studies Like This,” McCann Also Explained, “Is That’s Not Just Genes That Dictate Our Brain Health-other factors such as Nutrition, Metabolism, and The Gut-Boin Connection Play A Crucial Role.”
“Combining these features could Help Us Predict and Spot Conditions Such as Alzheimer’s and Parkinson’s Earlier than Ever Before,” She Added.
As is off the case with Scientific Research, This Recent Study Also Leaves Sub Unnswered Questions.
For Instance, “It is not yet Clear Whether Gut and Metabolic Disorders Directly Cause Neurodegeneration or Whether They Reflect Shared Underlying Processions Such As Mithochondrial Dysfunction and Chronic Inflammation,” Perlmutter Told MNT.
“BeSe mechanisms are Central to the Shift of Microglial Cells to a Pro-Inflammatory State, which is an emerging mechanism in neurodegenerative condition,” “he noted.




